vimarsana.com
Home
Live Updates
Biomarker in Blood Predicts Multiple Sclerosis Progression 1
Biomarker in Blood Predicts Multiple Sclerosis Progression 1
Biomarker in Blood Predicts Multiple Sclerosis Progression 1 to 2 Years in Advance
Researchers has found that elevated levels of NfL in the blood of multiple sclerosis (MS) patients could signal worsening disability within the next one to two years.
Related Keywords
Switzerland ,
United States ,
Swiss ,
Americans ,
Jens Kuhle ,
Suzanne Leigh ,
Pascal Benkert ,
Ahmed Abdelhak ,
Swiss National Research Foundation ,
University Hospital ,
Department Of Neurology ,
Westridge Foundation ,
Neuroinflammation Center ,
Valhalla Foundation ,
University Of Basel ,
Weill Institute For Neurosciences ,
University Of California San Francisco ,
Sclerosis Center At University Hospital ,
National Ms Society ,
Weill Institute ,
Elevated Nfl ,
Expanded Disability Status ,
Bari Green ,
Multiple Sclerosis Center ,
Westridge Foundation Grants ,
Fishman Family ,
Light Chain Elevation ,
Disability Progression ,
California San Francisco ,
Swiss Multiple Sclerosis Cohort ,
Expanded Disability Status Scale ,
Neuroscience Newsletter ,